Healthcare provider profile · identity verified

Jay K Gusler, MD

Family Practice · TACOMA, WA · NPI 1831281401

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	501	140
Amlodipine Besylate	Amlodipine Besylate	335	91
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	270	47
Lisinopril	Lisinopril	270	79
Levothyroxine Sodium	Levothyroxine Sodium	262	72
Metoprolol Succinate	Metoprolol Succinate	232	59
Rosuvastatin Calcium	Rosuvastatin Calcium	201	59
Losartan Potassium	Losartan Potassium	194	54
Omeprazole	Omeprazole	194	53
Metformin Hcl	Metformin Hcl	182	48
Gabapentin	Gabapentin	166	49
Tamsulosin Hcl	Tamsulosin Hcl	148	43
Glimepiride	Glimepiride	145	44
Hydrochlorothiazide	Hydrochlorothiazide	143	51
Oxycodone Hcl	Oxycodone Hcl	136	23
Allopurinol	Allopurinol	124	31
Simvastatin	Simvastatin	123	39
Tramadol Hcl	Tramadol Hcl	106	16
Sertraline Hcl	Sertraline Hcl	101	30
Pantoprazole Sodium	Pantoprazole Sodium	98	34
Furosemide	Furosemide	96	40
Alprazolam	Alprazolam	93	27
Metformin Hcl Er	Metformin Hcl	93	27
Duloxetine Hcl	Duloxetine Hcl	88	15
Albuterol Sulfate Hfa	Albuterol Sulfate	86	33
Alendronate Sodium	Alendronate Sodium	83	20
Escitalopram Oxalate	Escitalopram Oxalate	78	20
Olmesartan Medoxomil	Olmesartan Medoxomil	78	25
Venlafaxine Hcl Er	Venlafaxine Hcl	77	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	76	21
Trazodone Hcl	Trazodone Hcl	67	19
Methocarbamol	Methocarbamol	62	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	61	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	61	suppressed
Montelukast Sodium	Montelukast Sodium	60	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	59	20
Meloxicam	Meloxicam	59	22
Jardiance	Empagliflozin	58	17
Pioglitazone Hcl	Pioglitazone Hcl	58	15
Zolpidem Tartrate	Zolpidem Tartrate	57	17
Fluticasone Propionate	Fluticasone Propionate	54	24
Carvedilol	Carvedilol	53	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	53	13
Pregabalin	Pregabalin	53	11
Ozempic	Semaglutide	50	suppressed
Xarelto	Rivaroxaban	49	13
Clonazepam	Clonazepam	48	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	17
Ezetimibe	Ezetimibe	48	14
Potassium Chloride	Potassium Chloride	47	18
Lamotrigine	Lamotrigine	46	suppressed
Temazepam	Temazepam	46	suppressed
Lovastatin	Lovastatin	45	13
Famotidine	Famotidine	43	14
Spironolactone	Spironolactone	42	12
Diclofenac Sodium	Diclofenac Sodium	40	11
Telmisartan	Telmisartan	39	14
Estradiol	Estradiol	38	13
Acyclovir	Acyclovir	37	suppressed
Donepezil Hcl	Donepezil Hcl	36	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	36	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	35	suppressed
Eliquis	Apixaban	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Diazepam	Diazepam	33	suppressed
Felodipine Er	Felodipine	33	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	32	suppressed
Fenofibrate	Fenofibrate	31	11
Lorazepam	Lorazepam	31	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Farxiga	Dapagliflozin Propanediol	30	suppressed
Finasteride	Finasteride	30	suppressed
Buspirone Hcl	Buspirone Hcl	29	suppressed
Mounjaro	Tirzepatide	29	suppressed
Tizanidine Hcl	Tizanidine Hcl	29	11
Triamcinolone Acetonide	Triamcinolone Acetonide	29	15
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Atenolol	Atenolol	27	suppressed
Clonidine Hcl	Clonidine Hcl	27	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	25	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Glipizide Er	Glipizide	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Prednisone	Prednisone	24	13
Baclofen	Baclofen	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Propranolol Hcl Er	Propranolol Hcl	23	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Dutasteride	Dutasteride	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Morphine Sulfate Er	Morphine Sulfate	20	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	20	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Valacyclovir	Valacyclovir Hcl	19	suppressed
Bupropion Hcl Sr	Bupropion Hcl	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Olanzapine	Olanzapine	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Raloxifene Hcl	Raloxifene Hcl	15	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Naproxen	Naproxen	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	14	suppressed
Solifenacin Succinate	Solifenacin Succinate	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Synthroid	Levothyroxine Sodium	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	13	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Etodolac	Etodolac	13	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	13	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Topiramate	Topiramate	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Dilt-Xr	Diltiazem Hcl	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Mirtazapine	Mirtazapine	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Telmisartan-Hydrochlorothiazid	Telmisartan/Hydrochlorothiazid	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error